期刊文献+

氯法拉滨对NB4细胞的增殖抑制作用及对Bcl-2表达的影响 被引量:3

Effect of Clofarabine on Proliferation and Bcl-2 Expression of NB4 Cells
在线阅读 下载PDF
导出
摘要 本研究观察氯法拉滨对人急性髓系白血病NB4细胞的增殖抑制作用并探讨其可能的作用机制。用MTT法观察氯法拉滨0.01-0.1μmol/L作用于NB4细胞48 h的增殖抑制作用;氯法拉滨0.01-0.1μmol/L作用于NB4细胞24 h后,用流式细胞术分析其细胞的凋亡水平,Western blot检测细胞内Bcl-2的蛋白表达。结果表明,氯法拉滨对NB4细胞具有浓度依赖性增殖抑制作用。氯法拉滨作用24 h后,NB4细胞凋亡率明显增加,Bcl-2蛋白表达下调。结论:氯法拉滨能抑制NB4细胞增殖,其作用机制可能与下调Bcl-2的蛋白表达,诱导NB4细胞凋亡有关。 The aim of this study was to observe the effect of clofarabine on proliferation of NB4 cells and its possible mechanism.MTT method was used to detect proliferation of NB4 cells treated with clofarabine 0.01-0.1 μmol/L for 48 h.The treated with clofarabine 0.01-0.1 μmol/L for 24 h,apoptosis rate and Bcl-2 expression of NB4 cells were measured by flow cytometry and Western blot respectively.The results showed that clofarabine inhibited proliferation of NB4 cells in a concentration-depended manner(r=0.78).After treated with clofarabine for 24 h,apoptosis rate of NB4 cells increased and Bcl-2 expression in NB4 cells decreased obviously(P〈0.05).It is concluded that clofarabine inhibits proliferation of NB4 cells,which may be related with the down-regulation of Bcl-2 and induction of apoptosis.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第3期571-573,共3页 Journal of Experimental Hematology
关键词 氯法拉滨 NB4细胞 BCL-2表达 clofarabine NB4 cell line Bcl-2 expression
  • 相关文献

参考文献10

  • 1Jeha S, Kantariian H. Clofarabine for the treatment of acute lymphoblastic leukemia. Expert Rev Anticancer Ther,2007 ;7 (2) : 113 -118.
  • 2Hannun YA. Apoptosis and the dilemma of cancer chemotherapy. Blood, 1997;89(6):1845-1853.
  • 3McDonald LR, McCarthy CH. Nursing considerations for clofarabine in the treatment of acute lymphoblastic leukemia in children. Clin J Oncol Nurs, 2006;10(6) :809 -815.
  • 4Pattingre S, Tassa A, Qu XP, et al. Bcl-2 antiapoptosis proteins inhibit Beclin 1 -dependent autophagy. Cell, 2005 ; 122 ( 6 ) : 927 - 939.
  • 5Atkinson EA, Barry M, Darmon AJ, et al. Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B. J Biol Chem, 1998;273 (33) :21261 -21266.
  • 6Boise LH, Thompson CB. Bcl-x (L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc Natl Acad Sci USA, 1997 ;94 (8) :3759 - 3764.
  • 7Saelens X, Festjens N, Vande Walle L, et al. Toxic proteins released from mitochondria in cell death. Oncogene,2004 ;23 ( 16 ) : 2861 - 2874.
  • 8Steganis L. Caspase-dependent and independent neuronal death:two distinct pathways to neuronal injury. Neuroscientist, 2005 ; 1 I ( 1 ) : 50 -62.
  • 9Hirsch T, Dallaporta B, Zamzami N, et al. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis. Immunology, 1998 ; 161 ( 1 ) : 35 -40.
  • 10Boatright KM, Salvesen GS. Mechanisms of caspase activation. Curr Opin Cell Biol, 2003; 15(6) :725 -731.

同被引文献30

  • 1Majhail NS, Lichtin AE. Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J Med, 2004; 71 (8) : 633 -637.
  • 2Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene, 2003 ; 22 ( 53 ) : 8590 - 8607.
  • 3Kelly PN, Strasser A. The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ, 2011; 18 (9) : 1414-1424.
  • 4Reed JC. Bcl-2-family proteins and hematologic malignancies: history and future prospects. Blood, 2008 ; 111 (7) : 3322 - 3230.
  • 5Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochon-drial apoptotic pathways in cancer therapy. Clin Cancer Res, 2009; 15 (4) : 1126 -1132.
  • 6Kang MH, Reynolds CP. Bcl-2 inhibitors : targeting mitochon-drial apoptotic pathways in cancer therapy. Clin Caucer Res, 2009; 15 (4) : 1126 -1132.
  • 7Campos L, Rouault JP, Sabido O, et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood, 1993 ; 81 ( 11 ) : 3091 - 3906.
  • 8Tas F, Duranyildiz D, Oguz H, et al. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non- small cell lung cancer. Cancer Invest, 2006; 24 (6) : 576 -580.
  • 9Tas F, Duranyildiz D, Argon A, et al. Serum bcl-2 and survivin levels in melanoma. Melanoma Res, 2004; 14 (6) : 543 -546.
  • 10E1-Shakankiry NH, E1-Sayed GM, E1-Maghraby S, et al. Bcl-2 protein expression in egyptian acute myeloid leukemia. J Egypt Natl Canc Inst, 2009;21 (1) : 71 -76.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部